ARCHIVES

HHS Task Force Says NCI Drug Program Effective, Otters Suggestions; DeVita Responds

This article is from The Cancer Letter archive.

Vol. 08 No. 13 | March 26, 1982

Download PDF Visit The Full Archive

Related Articles

President’s Cancer Panel Lists Recommendations For Improving Quality Of Cancer Care

April 9, 1999

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

February 20, 1998

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998

RFA On Pathology Training Released

February 1, 1980

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005